Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Our Company

More Than Just Gossip...

Today's Top Reads Close

Dominic Tyer at Pharmafocus recently said the following in an article about health blogs:

Blogs have more to offer than just a home for pharma gossip

Well, I should hope so!

In this article Dominic raises some interesting points about corporate blogging, including the challenges of working in a regulated environment and the way bloggers are breaking real news.

It was nice to see that JNJBTW was mentioned, but there were a few things in the article that didn't seem quite right. For instance, according to Dominic, GlaxoSmithKline and Johnson & Johnson launched

... pharma's first official blogs within days of each other, with low-cut, viral marketing strategies designed to appeal directly to the blogosphere.

Ok. Though I bristle when Johnson & Johnson is described as a "pharma" company (Johnson & Johnson's operating companies also sell medical devices, diagnostics and consumer products -- pharmaceuticals are just one part of the business) I have heard people make that mistake before. However, I wasn't aware that I had used a "viral marketing strategy" to let people know about JNJBTW.

He went on to say that

The JnJ site covers a wider range of topics and has a single lead author taken from within the company's media relations team, which may give it the edge when it comes to developing a unique voice.

Hmmm... Bill Price, who sits just a few doors down from me, made his first post a couple of weeks ago and we hope to be joined by a few others -- but I do get Dominic's point about developing an authentic voice. That's important.

But the following point really jarred:

This highlights the challenge companies face in the blogosphere. There is no control over the message and the message can be read and added to by anyone. This presents a tricky issue for pharma when it comes to corporate PR and there are no easy answers.

I think I get what Dominic is trying to say, but I don't agree. Lack of control isn't necessarily a bad thing. In fact, without an intermediary in "control" of the message, mistakes or misperceptions can be self-corrected in the blogosphere as the facts are laid out, added to and disseminated by others.

Through JNJ BTW I'm trying to provide a bit more insight into what Johnson & Johnson is doing and why, occasionally adding my thoughts about the news of the day or other trends. This isn't about control -- it's about having a voice in the conversation. As I mentioned in a previous post, public relations should be about "truth well told" . By adding perspective, context and details whenever possible, in the end "truth will out" in the blogosphere.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.